These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 18642013)

  • 1. Successful pregnancy outcome with 5-flurouracil, epirubicin, cyclophosphamide chemotherapy, and hemostatic radiotherapy with abdominal shielding for metastatic invasive intraductal breast carcinoma.
    Sharma JB; Pushparaj M; Kumar S; Roy KK; Raina V; Malhotra N
    Arch Gynecol Obstet; 2009 Mar; 279(3):415-7. PubMed ID: 18642013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Breast carcinoma and pregnancy. A case report].
    Serrano Migallón JA; Sandoval Guerrero F; Miranda Hernández H; de la Garza Navarro JM
    Ginecol Obstet Mex; 1988 Oct; 56():281-4. PubMed ID: 2856450
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined chemotherapy and radiotherapy during conception and first two trimesters of gestation in a woman with metastatic breast cancer.
    Andreadis C; Charalampidou M; Diamantopoulos N; Chouchos N; Mouratidou D
    Gynecol Oncol; 2004 Oct; 95(1):252-5. PubMed ID: 15385141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for breast cancer during pregnancy: an 18-year experience from five London teaching hospitals.
    Ring AE; Smith IE; Jones A; Shannon C; Galani E; Ellis PA
    J Clin Oncol; 2005 Jun; 23(18):4192-7. PubMed ID: 15961766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal chemotherapy-induced encephalopathy following high-dose therapy for metastatic breast cancer: a case report and review of the literature.
    Cossaart N; SantaCruz KS; Preston D; Johnson P; Skikne BS
    Bone Marrow Transplant; 2003 Jan; 31(1):57-60. PubMed ID: 12621508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for breast cancer during pregnancy.
    Mathelin C; Annane K; Dufour P; Liegeois P; Bergerat JP
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):260-2. PubMed ID: 16024158
    [No Abstract]   [Full Text] [Related]  

  • 7. Specific congenital malformations after exposure to cyclophosphamide, epirubicin and 5-fluorouracil during the first trimester of pregnancy.
    Leyder M; Laubach M; Breugelmans M; Keymolen K; De Greve J; Foulon W
    Gynecol Obstet Invest; 2011; 71(2):141-4. PubMed ID: 21160143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epirubicin for breast cancer during pregnancy: a case report.
    Eedarapalli P; Biswas N; Coleman M
    J Reprod Med; 2007 Aug; 52(8):730-2. PubMed ID: 17879836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature.
    Gadducci A; Cosio S; Fanucchi A; Nardini V; Roncella M; Conte PF; Genazzani AR
    Anticancer Res; 2003; 23(6D):5225-9. PubMed ID: 14981994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pneumo- and cardiotoxic side effects following combination chemotherapy with epirubicin and ifosfamide].
    Franzen D; Pöhler E; Hilger HH
    Med Klin (Munich); 1990 Mar; 85 Suppl 1():133-6, 170. PubMed ID: 2160577
    [No Abstract]   [Full Text] [Related]  

  • 11. Multimodal cancer therapy for breast cancer in the first trimester of pregnancy. A case report.
    Murray CL; Reichert JA; Anderson J; Twiggs LB
    JAMA; 1984 Nov; 252(18):2607-8. PubMed ID: 6092731
    [No Abstract]   [Full Text] [Related]  

  • 12. Sclerotic and retracted supravenous hyperpigmentation associated with combination chemotherapy for metastatic breast carcinoma.
    Chen GY; Lee JY; Chen WC
    Br J Dermatol; 2005 Jun; 152(6):1383-5. PubMed ID: 15949026
    [No Abstract]   [Full Text] [Related]  

  • 13. Adriamycin and cyclophosphamide chemotherapy in advanced breast cancer in pregnancy.
    Skrablin S; Banović V; Matković V
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):251-2. PubMed ID: 16860457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and histologic effects of preoperative combination chemotherapy of breast cancer].
    Wang ZY
    Zhonghua Wai Ke Za Zhi; 1988 Nov; 26(11):648-50, 700. PubMed ID: 2855506
    [No Abstract]   [Full Text] [Related]  

  • 15. New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients.
    Ryberg M; Nielsen D; Cortese G; Nielsen G; Skovsgaard T; Andersen PK
    J Natl Cancer Inst; 2008 Aug; 100(15):1058-67. PubMed ID: 18664656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokinetic-based versus conventional chemotherapy in metastatic breast cancer: a randomized study.
    Conte PF; Rubagotti A; Falcone A; Gardin G; Nicolin A; Pronzato P; Rosso R; Amadori D; Gentilini P; Sismondi P
    Chemioterapia; 1987 Jun; 6(2 Suppl):712-3. PubMed ID: 3334664
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibilities of the cytological method in the determination of therapeutic pathomorphosis of breast cancer].
    Sidorova NA; Volchenko NN; Saribekian EK
    Sov Med; 1991; (11):15-8. PubMed ID: 1662831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal effects of breast cancer chemotherapy administered during pregnancy.
    Kerr JR
    Pharmacotherapy; 2005 Mar; 25(3):438-41. PubMed ID: 15843292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High total dose 5-fluorouracil treatment during pregnancy.
    Dreicer R; Love RR
    Wis Med J; 1991 Oct; 90(10):582-3. PubMed ID: 1771920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cis-platinum combination chemotherapy during pregnancy for advanced epithelial ovarian carcinoma.
    Malfetano JH; Goldkrand JW
    Obstet Gynecol; 1990 Mar; 75(3 Pt 2):545-7. PubMed ID: 2304734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.